{
    "clinical_study": {
        "@rank": "74000", 
        "acronym": "ProTool", 
        "arm_group": {
            "arm_group_label": "ProTool", 
            "arm_group_type": "Experimental", 
            "description": "Device:   Molecular and cellular tumor print Medical Device (ProTool)"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to determine the innocuity and operability of the innovative\n      tumor molecular and cellular print ProTool."
        }, 
        "brief_title": "Multicenter Safety Trial Assessing an Innovative Tumor Molecular and Cellular Print Medical Device in Glioma", 
        "completion_date": {
            "#text": "August 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Glioma : Oligodendroglioma or Astrocytoma", 
        "condition_browse": {
            "mesh_term": [
                "Astrocytoma", 
                "Glioma", 
                "Oligodendroglioma"
            ]
        }, 
        "detailed_description": {
            "textblock": "Diagnostic in cancerology keeps based on biopsy or exeresis tissues anatomopathologic\n      analysis. Micro-invasive biopsy approaches reduces chirurgical aggressivity but also tissue\n      amount The innovative Medical Device ProTool offers a micro-invasive biopsy approach in\n      parallel with classical chirurgical proceeding. It allows to complete heterogeneity tumoral\n      analysis and peri-tumoral tissue environment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  more or equal than 18 years old\n\n          -  patient affiliated to social security or similarly regime\n\n          -  informed consent form signed\n\n          -  glial tumor suspicion\n\n          -  Stereotaxic biopsy indication\n\n          -  Karnofsky score > 70%\n\n          -  Hematological assessment :\n\n          -  neutrophils > 1500/mm3\n\n          -  Platelet  > 150 000\n\n          -  blood Creatinin normal\n\n          -  alkaline Phosphatases and transaminases no more than two times normal\n\n          -  Bilirubin < 1.5 times normal\n\n        Exclusion Criteria:\n\n          -  Pregnant women and lactating mothers\n\n          -  Ward of court or under guardianship\n\n          -  Adult unable to express their consent\n\n          -  Person deprived of freedom by judicial or administrative decision\n\n          -  Person hospitalized without their consent\n\n          -  Person under legal protection\n\n          -  Person participating in another clinical study\n\n          -  Intratumoral hemorrhage MRI detected\n\n          -  Treatment anticoagulant or antisludge treatments\n\n          -  Active Infections and non controled or medical affection or psychiatric intercurrent\n             non treated\n\n          -  Evolutive cerebral oedema without corticoid response\n\n          -  Non controled Epilepsy without antiepileptics response\n\n          -  Susceptibility to Medical Device materials allergy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077543", 
            "org_study_id": "ProTool"
        }, 
        "intervention": {
            "arm_group_label": "ProTool", 
            "description": "Proteomic, genomic and cellular culture", 
            "intervention_name": "Molecular and cellular tumor print Medical Device (ProTool)", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 28, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Philippe MENEI, MD, PhD"
                }, 
                "contact_backup": {
                    "last_name": "Caroline SANDRE-BALLESTER, PhD", 
                    "phone": "+33 4 38 78 28 51"
                }, 
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France"
                    }, 
                    "name": "Angers University Hospital"
                }, 
                "investigator": {
                    "last_name": "Philippe MENEI, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "St\u00e9phane PALFI, MD, PhD"
                }, 
                "contact_backup": {
                    "email": "csandreballester@chu-grenoble.fr", 
                    "last_name": "Caroline SANDRE-BALLESTER, PhD", 
                    "phone": "+33 4 38 78 28 51"
                }, 
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France"
                    }, 
                    "name": "Henri Mondor University Hospital"
                }, 
                "investigator": {
                    "last_name": "St\u00e9phane PALFI, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "francois.berger@cea.fr", 
                    "last_name": "Fran\u00e7ois , MD, PhD"
                }, 
                "contact_backup": {
                    "email": "csandreballester@chu-grenoble.fr", 
                    "last_name": "Caroline SANDRE-BALLESTER, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38000"
                    }, 
                    "name": "CLINATEC"
                }, 
                "investigator": {
                    "last_name": "Fran\u00e7ois BERGER, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "EGay@chu-grenoble.fr", 
                    "last_name": "Emmanuel GAY, MD, PhD"
                }, 
                "contact_backup": {
                    "email": "csandreballester@chu-grenoble.fr", 
                    "last_name": "Caroline SANDRE-BALLESTER, PhD", 
                    "phone": "+33 4 38 78 28 51"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38000"
                    }, 
                    "name": "Grenoble University Hospital"
                }, 
                "investigator": {
                    "last_name": "Emmanuel GAY, Pr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bertrand DEVAUX, Pr"
                }, 
                "contact_backup": {
                    "email": "csandreballester@chu-grenoble.fr", 
                    "last_name": "Caroline SANDRE-BALLESTER, PhD", 
                    "phone": "+33 4 38 78 28 51"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75000"
                    }, 
                    "name": "Sainte-Anne Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Molecular and Cellular Print Medical Device Validation in Adult Glioma Tumors", 
        "overall_contact": {
            "email": "francois.berger@cea.fr", 
            "last_name": "Fran\u00e7ois BERGER, MD, PhD", 
            "phone": "+ 33 4 38 78 15 18"
        }, 
        "overall_contact_backup": {
            "email": "csandreballester@chu-grenoble.fr", 
            "last_name": "Caroline SANDRE-BALLESTER, PhD", 
            "phone": "+ 33 4 38 78 28 51"
        }, 
        "overall_official": {
            "affiliation": "University Grenoble Hospital", 
            "last_name": "Fran\u00e7ois BERGER, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Clinical examination : neurologic deficiency, allergic reaction, infections, pain, headaches, others adverse events... Postoperative MRI evaluation : no hematoma", 
                "safety_issue": "Yes", 
                "time_frame": "2 hours after surgery"
            }, 
            {
                "measure": "Clinical examination : neurologic deficiency, allergic reaction, infections, pain, headaches, others adverse events... Postoperative MRI evaluation : no hematoma", 
                "safety_issue": "Yes", 
                "time_frame": "one month after surgery"
            }, 
            {
                "measure": "Clinical examination : neurologic deficiency, allergic reaction, infections, pain, headaches, others adverse events... Postoperative MRI evaluation : no hematoma", 
                "safety_issue": "Yes", 
                "time_frame": "3 months after surgery"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077543"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Molecular measurements in intra-operative cellular samples : transcriptome, micro-RNA, proteome and cellular cultur analysis", 
            "safety_issue": "No", 
            "time_frame": "up to 1 month after surgery"
        }, 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}